HUT47153A - Process for producing recombinant dna sequence encoding human proapolypoprotein a-i, expression vector comprising it, as well as human proapolypoprotein a-i by applying same - Google Patents
Process for producing recombinant dna sequence encoding human proapolypoprotein a-i, expression vector comprising it, as well as human proapolypoprotein a-i by applying sameInfo
- Publication number
- HUT47153A HUT47153A HU882707A HU270788A HUT47153A HU T47153 A HUT47153 A HU T47153A HU 882707 A HU882707 A HU 882707A HU 270788 A HU270788 A HU 270788A HU T47153 A HUT47153 A HU T47153A
- Authority
- HU
- Hungary
- Prior art keywords
- proapolypoprotein
- human
- recombinant dna
- well
- expression vector
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
The present invention provides recombinant DNA sequences comprising a sequence which codes for human proapolipoprotein A-I wherein part of the natural coding sequence has been replaced by a DNA fragment coding for the same amino acids but consisting of a different nucleotide sequence such as to reduce or prevent formation of hairpins, cloning and expression vectors containing these DNA sequences, cell cultures or microorganisms transformed with these expression vectors and processes using the same for the production of proapolipoprotein A-I.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878712540A GB8712540D0 (en) | 1987-05-28 | 1987-05-28 | Expression of human proapolipoprotein a-i |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT47153A true HUT47153A (en) | 1989-01-30 |
HU204562B HU204562B (en) | 1992-01-28 |
Family
ID=10618034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU882707A HU204562B (en) | 1987-05-28 | 1988-05-27 | Process for producing recombinant dns-sequency codin human proapolypo-protein a-i, expressing vector containing them, transformed hoste celle and human proapolypoprotein a-i |
Country Status (33)
Country | Link |
---|---|
US (1) | US5059528A (en) |
EP (1) | EP0293357B1 (en) |
JP (1) | JP2634193B2 (en) |
KR (1) | KR970000808B1 (en) |
CN (1) | CN1031892C (en) |
AT (1) | ATE89006T1 (en) |
AU (1) | AU615654B2 (en) |
CA (1) | CA1323851C (en) |
CY (1) | CY1809A (en) |
CZ (1) | CZ283648B6 (en) |
DD (1) | DD291093A5 (en) |
DE (1) | DE3880739T2 (en) |
DK (1) | DK175686B1 (en) |
EG (1) | EG19101A (en) |
ES (1) | ES2054878T3 (en) |
FI (1) | FI100056B (en) |
GB (1) | GB8712540D0 (en) |
HK (1) | HK137794A (en) |
HU (1) | HU204562B (en) |
IE (1) | IE62422B1 (en) |
IL (1) | IL86480A (en) |
LT (1) | LT3600B (en) |
LV (1) | LV5288A3 (en) |
NO (1) | NO179253C (en) |
NZ (1) | NZ224808A (en) |
PL (1) | PL158064B1 (en) |
PT (1) | PT87562B (en) |
RU (1) | RU2009198C1 (en) |
SG (1) | SG131594G (en) |
SK (1) | SK363888A3 (en) |
SU (1) | SU1834904A3 (en) |
UA (1) | UA19765A (en) |
ZA (1) | ZA883824B (en) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU587989B2 (en) * | 1984-10-16 | 1989-09-07 | Mitsubishi Chemical Corporation | DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins |
JP2606228B2 (en) * | 1987-09-18 | 1997-04-30 | 三菱化学株式会社 | Method for producing human proapolipoprotein AI-like protein |
DE68917379T2 (en) * | 1988-05-31 | 1994-12-01 | Mitsubishi Chem Ind | Process for the production of proteins similar to natural human apolipoprotein-E. |
US5460961A (en) * | 1988-06-14 | 1995-10-24 | La Region Wallonne | Human myeloperoxidase and its therapeutic application |
US5846799A (en) * | 1988-06-14 | 1998-12-08 | La Region Wallone | Human myeloperoxidase and its therapeutic application |
IT1229996B (en) * | 1989-04-20 | 1991-09-20 | Cesare Sirtori | EXPRESSION OF APOLIPOPROTEIN AI AND APOLIPOPROTEIN AI-MILAN IN YEAST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE APOLIPOPROTEINS. |
IE914102A1 (en) * | 1990-11-26 | 1992-06-03 | Genetics Inst | Expression of pace in host cells and methods of use thereof |
US5844097A (en) * | 1990-11-30 | 1998-12-01 | Monoclonetics International, Inc. | Methods for the diagnosis of peripheral nerve damage |
AU667462B2 (en) * | 1990-11-30 | 1996-03-28 | Monoclonetics International Incorporated | Methods for the diagnosis of chronic lower back and cervical pain |
SE9500778D0 (en) * | 1995-03-03 | 1995-03-03 | Pharmacia Ab | Process for producing a protein |
US5994061A (en) * | 1995-09-29 | 1999-11-30 | Queen's University At Kingston | DNA constructs and methods for screening for increased expression of human apo AI gene |
SE9603068D0 (en) * | 1996-08-23 | 1996-08-23 | Pharmacia & Upjohn Ab | Process for purifying a protein |
SE9603304D0 (en) * | 1996-09-11 | 1996-09-11 | Pharmacia & Upjohn Ab | Process for purifying a compound |
SE9603303D0 (en) | 1996-09-11 | 1996-09-11 | Pharmacia & Upjohn Ab | Process for purifying a protein |
KR100330355B1 (en) * | 1999-06-04 | 2002-04-01 | 장인순 | Duct type spacer grid with swirl flow vane in nuclear fuel assembly |
US20040047853A1 (en) * | 2000-06-09 | 2004-03-11 | Dahl Soren W | Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |
JP2004530417A (en) * | 2000-12-12 | 2004-10-07 | レキシコン・ジェネティクス・インコーポレーテッド | Novel human kinase and polynucleotide encoding it |
KR100560102B1 (en) * | 2004-06-25 | 2006-03-13 | 한국생명공학연구원 | Prophylactic and therapeutic agents containing point mutants of proapolipoprotein A-I for anti-atherosclerosis and anti-hyperlipidemia |
US7427662B2 (en) * | 2005-02-01 | 2008-09-23 | Baord Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein |
US8206750B2 (en) | 2005-03-24 | 2012-06-26 | Cerenis Therapeutics Holding S.A. | Charged lipoprotein complexes and their uses |
CN101253195A (en) * | 2005-08-26 | 2008-08-27 | 科莱尼斯医疗控股公司 | Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria |
WO2008104890A2 (en) * | 2007-02-28 | 2008-09-04 | Cerenis Therapeutics Holding Sa | Compositions and methods for producing apolipoprotein |
MX339820B (en) * | 2008-10-03 | 2016-06-13 | Curna Inc | Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1. |
AU2009313201B2 (en) | 2008-11-10 | 2016-06-16 | Arbutus Biopharma Corporation | Novel lipids and compositions for the delivery of therapeutics |
CA3036963A1 (en) | 2009-01-29 | 2010-08-05 | Arbutus Biopharma Corporation | Lipid formulations comprising cationic lipid and a targeting lipid comprising n-acetyl galactosamine for delivery of nucleic acid |
EP2406376A1 (en) | 2009-03-12 | 2012-01-18 | Alnylam Pharmaceuticals, Inc. | LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES |
KR20220150411A (en) | 2009-05-05 | 2022-11-10 | 알닐람 파마슈티칼스 인코포레이티드 | Lipid compositions |
JP5883782B2 (en) | 2009-05-06 | 2016-03-15 | クルナ・インコーポレーテッド | Treatment of lipid transport metabolism gene-related diseases by suppression of natural antisense transcripts on lipid transport metabolism genes |
PL3431076T3 (en) | 2009-06-10 | 2022-01-31 | Arbutus Biopharma Corporation | Improved lipid formulation |
US9029338B2 (en) | 2009-08-14 | 2015-05-12 | Alnylam Pharmaceuticals, Inc. | Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus |
WO2011044545A2 (en) | 2009-10-09 | 2011-04-14 | Sigalov Alexander B | Methods and compositions for targeted imaging |
US10894098B2 (en) | 2012-04-09 | 2021-01-19 | Signablok, Inc. | Methods and compositions for targeted imaging |
EP3296398A1 (en) | 2009-12-07 | 2018-03-21 | Arbutus Biopharma Corporation | Compositions for nucleic acid delivery |
CA2784568A1 (en) | 2009-12-18 | 2011-06-23 | Martin A. Maier | Lipid particles for delivery of nucleic acids |
WO2011139911A2 (en) | 2010-04-29 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Lipid formulated single stranded rna |
WO2011143362A1 (en) | 2010-05-11 | 2011-11-17 | Esperion Therapeutics, Inc. | Dimeric oxidation-resistant apolipoprotein a1 variants |
KR20190039347A (en) | 2010-06-03 | 2019-04-10 | 알닐람 파마슈티칼스 인코포레이티드 | Biodegradable lipids for the delivery of active agents |
US20130323269A1 (en) | 2010-07-30 | 2013-12-05 | Muthiah Manoharan | Methods and compositions for delivery of active agents |
US20130202652A1 (en) | 2010-07-30 | 2013-08-08 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for delivery of active agents |
CN110123830A (en) | 2010-11-09 | 2019-08-16 | 阿尔尼拉姆医药品有限公司 | Composition and method for inhibiting the lipid of the expression of Eg5 and VEGF gene to prepare |
AU2012207606B2 (en) | 2011-01-11 | 2017-02-23 | Alnylam Pharmaceuticals, Inc. | Pegylated lipids and their use for drug delivery |
SI2673296T1 (en) | 2011-02-07 | 2019-03-29 | Cerenis Therapeutics Holding Sa | Lipoprotein complexes and manufacturing and uses thereof |
EP2760477B1 (en) | 2011-09-27 | 2018-08-08 | Alnylam Pharmaceuticals, Inc. | Di-aliphatic substituted pegylated lipids |
WO2014011908A1 (en) | 2012-07-11 | 2014-01-16 | Esperion Therapeutics, Inc. | Apolipoprotein mixtures |
BR112015027377B1 (en) * | 2013-05-01 | 2023-01-10 | Ionis Pharmaceuticals, Inc | OLIGOMERIC COMPOUNDS WITH CONJUGATE GROUPS, COMPOSITIONS COMPRISING THE SAID COMPOUNDS AND USES THEREOF |
EP2853259A1 (en) | 2013-09-30 | 2015-04-01 | Université Pierre et Marie Curie (Paris 6) | Reconstituted high density lipoproteins composition and uses thereof |
KR20170003611A (en) | 2014-05-02 | 2017-01-09 | 세레니스 쎄라퓨틱스 홀딩 에스에이 | Hdl therapy markers |
CN108473990A (en) * | 2016-10-27 | 2018-08-31 | 中国科学院微生物研究所 | The remodeling method of amino acid attenuator and its application in production |
EP3668549A1 (en) | 2017-08-10 | 2020-06-24 | Abionyx Pharma SA | Apomers |
WO2019030574A1 (en) | 2017-08-10 | 2019-02-14 | Cerenis Therapeutics Holding | Cargomers |
US11081113B2 (en) | 2018-08-24 | 2021-08-03 | Bright Marbles, Inc. | Idea scoring for creativity tool selection |
US11164065B2 (en) | 2018-08-24 | 2021-11-02 | Bright Marbles, Inc. | Ideation virtual assistant tools |
US11461863B2 (en) | 2018-08-24 | 2022-10-04 | Bright Marbles, Inc. | Idea assessment and landscape mapping |
US11189267B2 (en) | 2018-08-24 | 2021-11-30 | Bright Marbles, Inc. | Intelligence-driven virtual assistant for automated idea documentation |
AU2021256086A1 (en) | 2020-04-16 | 2022-12-15 | Abionyx Pharma Sa | Methods for treating acute conditions using lipid binding protein- based complexes |
CA3197168A1 (en) | 2020-10-01 | 2022-04-07 | Abionyx Pharma Sa | Methods for treating eye diseases using lipid binding protein-based complexes |
AU2022258815A1 (en) | 2021-04-15 | 2023-10-19 | Abionyx Pharma Sa | Use of lipid binding protein-based complexes in organ preservation solutions |
WO2023194797A1 (en) | 2022-04-06 | 2023-10-12 | Abionyx Pharma Sa | Methods for treating eye diseases using lipid binding protein-based complexes |
WO2023194798A1 (en) | 2022-04-06 | 2023-10-12 | Abionyx Pharma Sa | Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding protein-based complexes |
WO2023237935A2 (en) | 2022-06-10 | 2023-12-14 | Abionyx Pharma Sa | Methods for treating acute conditions using lipid binding protein-based complexes |
WO2023237927A2 (en) | 2022-06-10 | 2023-12-14 | Abionyx Pharma Sa | Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU587989B2 (en) * | 1984-10-16 | 1989-09-07 | Mitsubishi Chemical Corporation | DMA fragments, expression vectors, proteins, hosts, and process for production of the proteins |
JPS6198998A (en) | 1984-10-18 | 1986-05-17 | Matsushita Electric Ind Co Ltd | Electric fan |
BE901119A (en) | 1984-11-23 | 1985-03-15 | Wallone Region | PROCESS FOR THE PREPARATION OF VECTOR PLASMIDS CAPABLE OF TRANSFORMING A BACTERIAL HOST ESCHERICHIA COLI AND OF PROMOTING AND CONTROLLING THE EXPRESSION OF HETEROLOGOUS DNA IN IT. |
AU580145B2 (en) | 1985-02-13 | 1989-01-05 | Scios Nova Inc. | Human metallothionein-ii promoter in mammalian expression system |
GB8507833D0 (en) * | 1985-03-26 | 1985-05-01 | Biogen Nv | Production of human somatomedin c |
WO1987002062A1 (en) | 1985-10-04 | 1987-04-09 | Biotechnology Research Partners, Ltd. | Recombinant apolipoproteins and methods |
GB8625435D0 (en) * | 1986-10-23 | 1986-11-26 | Erba Farmitalia | Human apolipoprotein ai |
AU8273987A (en) * | 1986-10-29 | 1988-05-25 | Biotechnology Research Partners Limited | Apoai-ciii-aiv, apoaii apob , apoci, and ldl receptor polymorphisms for genetic fingerprinting and predictive of atherosclerosis |
-
1987
- 1987-05-28 GB GB878712540A patent/GB8712540D0/en active Pending
-
1988
- 1988-05-16 CA CA000566894A patent/CA1323851C/en not_active Expired - Fee Related
- 1988-05-24 EP EP88870095A patent/EP0293357B1/en not_active Expired - Lifetime
- 1988-05-24 IL IL86480A patent/IL86480A/en not_active IP Right Cessation
- 1988-05-24 ES ES88870095T patent/ES2054878T3/en not_active Expired - Lifetime
- 1988-05-24 AT AT88870095T patent/ATE89006T1/en not_active IP Right Cessation
- 1988-05-24 PT PT87562A patent/PT87562B/en not_active IP Right Cessation
- 1988-05-24 DE DE8888870095T patent/DE3880739T2/en not_active Expired - Lifetime
- 1988-05-25 FI FI882456A patent/FI100056B/en not_active IP Right Cessation
- 1988-05-26 EG EG28288A patent/EG19101A/en active
- 1988-05-26 NZ NZ224808A patent/NZ224808A/en unknown
- 1988-05-26 UA UA4613079A patent/UA19765A/en unknown
- 1988-05-26 DD DD88316110A patent/DD291093A5/en not_active IP Right Cessation
- 1988-05-26 SU SU884356123A patent/SU1834904A3/en active
- 1988-05-26 PL PL1988272698A patent/PL158064B1/en unknown
- 1988-05-26 US US07/198,830 patent/US5059528A/en not_active Expired - Lifetime
- 1988-05-27 AU AU16723/88A patent/AU615654B2/en not_active Ceased
- 1988-05-27 CZ CS883638A patent/CZ283648B6/en not_active IP Right Cessation
- 1988-05-27 HU HU882707A patent/HU204562B/en not_active IP Right Cessation
- 1988-05-27 SK SK3638-88A patent/SK363888A3/en unknown
- 1988-05-27 CN CN88103118A patent/CN1031892C/en not_active Expired - Fee Related
- 1988-05-27 NO NO882341A patent/NO179253C/en not_active IP Right Cessation
- 1988-05-27 IE IE159788A patent/IE62422B1/en not_active IP Right Cessation
- 1988-05-27 ZA ZA883824A patent/ZA883824B/en unknown
- 1988-05-27 DK DK198802896A patent/DK175686B1/en not_active IP Right Cessation
- 1988-05-27 JP JP63130033A patent/JP2634193B2/en not_active Expired - Fee Related
- 1988-05-28 KR KR88006286A patent/KR970000808B1/en not_active IP Right Cessation
- 1988-12-20 RU SU884613079A patent/RU2009198C1/en active
-
1993
- 1993-06-01 LV LV930445A patent/LV5288A3/en unknown
- 1993-08-03 LT LTIP828A patent/LT3600B/en not_active IP Right Cessation
-
1994
- 1994-09-12 SG SG131594A patent/SG131594G/en unknown
- 1994-12-08 HK HK137794A patent/HK137794A/en not_active IP Right Cessation
-
1995
- 1995-10-20 CY CY180995A patent/CY1809A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT47153A (en) | Process for producing recombinant dna sequence encoding human proapolypoprotein a-i, expression vector comprising it, as well as human proapolypoprotein a-i by applying same | |
ES2089044T3 (en) | DNA FRAGMENT CODING A POLYPEPTIDE PRESENTING NITRILE HYDRATASE ACTIVITY, A TRANSFORMANT CONTAINING THE DNA FRAGMENT AND A PROCESS FOR THE PRODUCTION OF AMIDES USING THE TRANSFORMANT. | |
NO940736D0 (en) | DNA sequences encoding gelonin polypeptide | |
NO177570B (en) | Process for the preparation of peptides with fibronectin binding properties, microorganism and DNA sequence encoding peptides with fibronectin binding properties | |
EP0546087A4 (en) | ||
ZA935117B (en) | Anti-feline immunodeficiency virus (FIV) vaccines | |
FR2556365B1 (en) | INTERFERON-G CLONING AND EXPRESSION VECTORS, TRANSFORMED BACTERIA AND PROCESS FOR PREPARING INTERFERON-G | |
EP0422217A4 (en) | Human recombinant placental ribonuclease inhibitor and method of production | |
FR2792651A1 (en) | New nucleotide sequences isolated from Pyrococcus abyssi encode proteins useful in industry | |
IL78278A0 (en) | Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules | |
EP0183272A3 (en) | Vector capable of efficient gene expression and utilization of such vector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HPC4 | Succession in title of patentee |
Owner name: MINISTERE DE LA REGION WALLONNE, BE |
|
HMM4 | Cancellation of final prot. due to non-payment of fee |